A survey of the eye complications of leprosy in South Korea.
Courtright P, Green R, Pilarski R, Smucny J. Leprosy review. 1984; 55(3):229-37.
Combined therapy in principle and practice for the control of dapsone resistance.
Rees RJ. Leprosy review. 1978; 49(2):97-100.
Vasomotor reflex testing in leprosy patients, healthy contacts and controls: a cross-sectional study in western Nepal.
Wilder-Smith E, Wilder-Smith A, Van Brakel WH, Egger M. Leprosy review. 1996; 67(4):306-17.
The time interval between the start of anti-leprosy treatment and the development of reactions in borderline patients.
Naafs B, Wheate HW. Leprosy review. 1978; 49(2):153-7.
Superficial peroneal nerve thickening as an early diagnostic sign in leprosy.
Vaidyanathan EP, Vaidyanathan SI. Leprosy review. 1978; 49(2):149-51.
The dermatological clinic in a leprosy control scheme: 10 years' experience in Malawi.
Rampen F. Leprosy review. 1978; 49(2):141-7.
Proven primary dapsone resistance in leprosy--a case report.
Waters MF, Laing AB, Rees RJ. Leprosy review. 1978; 49(2):127-30.
Drugs for combined therapy: experimental studies on the antileprosy activity of ethionamide and prothionamide, and a general review.
Colston MJ, Ellard GA, Gammon PT. Leprosy review. 1978; 49(2):115-26.
A review of side-effects experienced by patients taking clofazimine.
Moore VJ. Leprosy review. 1983; 54(4):327-35.
An investigation of dapsone compliance using an isoniazid-marked formulation.
Stanley JN, Pearson JM, Ellard GA. Leprosy review. 1983; 54(4):317-25.
Use Ris for EndNote, Mendeley, RefWorks, Zotero and most other reference management software.